Celularity Inc — Director's Dealing 2021

Sep 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2021-09-13

Reporting Person: Mirakhur Beloo (EVP, Clinical Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-13	Stock Option (Right to Buy)	$6.87	A	125000	Acquired	2031-09-13	Class A Common Stock (125000)	Direct

Footnotes

F1: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, September 13, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and 1/48 of the total number of shares each month thereafter over the following three years, such that the options will be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service with the Issuer on each such date.